CosmosID

Rockville, United States Founded: 2008 • Age: 18 yrs
Next-generation sequencing technologies for microorganism detection are developed.
Request Access

About CosmosID

CosmosID is a company based in Rockville (United States) founded in 2008.. CosmosID has raised $7.32 million across 4 funding rounds from investors including Plug and Play Tech Center and Applied Value Group. CosmosID offers products and services including Amplicon Sequencing, Deep Shotgun Sequencing, Shallow Shotgun Sequencing, and Bacterial Isolate Sequencing. CosmosID operates in a competitive market with competitors including Trace Genomics, Kallyope, AnimalBiome, Macrogen and Microbiotica, among others.

  • Headquarter Rockville, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Cosmosid, Inc.
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $7.32 M (USD)

    in 4 rounds

  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of CosmosID

CosmosID offers a comprehensive portfolio of products and services, including Amplicon Sequencing, Deep Shotgun Sequencing, Shallow Shotgun Sequencing, and Bacterial Isolate Sequencing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Cost-effective profiling of microbial communities for taxonomic analysis.

Delivers detailed microbiome data through whole genome sequencing.

Enables species-level resolution for large cohort microbiome studies.

Identifies complete genetic makeup of bacterial isolates for diversity insights.

People of CosmosID
Headcount 10-50
Employee Profiles 2
Employee Profiles
People
Manoj Dadlani
President
People
Benjamin Briggs
Chief Medical Officer

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of CosmosID

CosmosID has successfully raised a total of $7.32M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round
  • First Round

    (16 Aug 2011)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2019 Amount Series B - CosmosID Valuation Plug and Play Tech Center
Jan, 2016 Amount Series B - CosmosID Valuation Applied Value Group
Sep, 2011 Amount Series A - CosmosID Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in CosmosID

CosmosID has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Plug and Play Tech Center and Applied Value Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Startups are accelerated and invested in across multiple tech sectors.
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by CosmosID

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - CosmosID

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Cosmosid Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of CosmosID

CosmosID operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Trace Genomics, Kallyope, AnimalBiome, Macrogen and Microbiotica, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of technologies to diagnose soil health and soil-borne disease prediction
domain founded_year HQ Location
The gut-brain axis is explored for therapeutic and nutritional innovations.
domain founded_year HQ Location
Animal microbiome diagnostics services for pet care are offered.
domain founded_year HQ Location
Next-generation sequencing and genomics services are provided globally.
domain founded_year HQ Location
Live bacterial therapeutics and biomarkers are developed for multiple diseases.
domain founded_year HQ Location
Genomic services are provided for the life sciences industry.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Cosmosid

Frequently Asked Questions about CosmosID

When was CosmosID founded?

CosmosID was founded in 2008 and raised its 1st funding round 3 years after it was founded.

Where is CosmosID located?

CosmosID is headquartered in Rockville, United States. It is registered at Rockville, Maryland, United States.

Is CosmosID a funded company?

CosmosID is a funded company, having raised a total of $7.32M across 4 funding rounds to date. The company's 1st funding round was a Series A of $100K, raised on Aug 16, 2011.

What does CosmosID do?

CosmosID was founded in 2008 and is based in Rockville, United States. Next-generation sequencing technologies are developed by the company for the detection of microorganisms in the biotechnology sector. The GENIUS software suite is utilized, which incorporates a curated genome database and proprietary algorithms to enable bacterial identification at the species, subspecies, or strain level. Operations focus on rapid analysis, with results typically available in minutes.

Who are the top competitors of CosmosID?

CosmosID's top competitors include Trace Genomics, BGI and Kallyope.

What products or services does CosmosID offer?

CosmosID offers Amplicon Sequencing, Deep Shotgun Sequencing, Shallow Shotgun Sequencing, and Bacterial Isolate Sequencing.

Who are CosmosID's investors?

CosmosID has 2 investors. Key investors include Plug and Play Tech Center, and Applied Value Group.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available